Medscape

FDA Approvals: BiPAP autoSV, Sentinel, Plexus HerpeSelect

March 12, 2007 — The US Food and Drug Administration (FDA) has granted 510(k) clearance for a device intended to provide ventilatory support for patients with sleep apnea, a data management system for ...
FierceBiotech

Philips cautions on cardio mortality after ResMed sleep apnea data, intros cardiac imaging tool

Royal Philips ($PHG) said it is working with ResMed ($RMD) to analyze study data from mid-May showing that the latter company's Adaptive Servo-Ventilation (ASV ...
Reuters

Respironics says FDA gives marketing approval to BiPAP autoSV

March 7 (Reuters) - Respironics Inc. said U.S. regulators granted approval to market its ventilatory support device, BiPAP autoSV, for sleep-disordered breathing patients. The company said the device ...
Reuters

Respironics receives 510(k) clearance from FDA for BiPAP autoSV device designed for complicated sleep-disordered breathing patients

Co announces that the FDA granted 510(k) clearance of the BiPAP autoSV device, which is intended to provide noninvasive ventilatory support to treat adult patients with Obstructive Sleep Apnea and ...
TCTMD

Philips Response to ResMed Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea and Chronic Heart Failure

On May 15, 2015, Respironics, Inc., a Philips business, provided the following response to ResMed's Update on Phase IV SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy in Central Sleep Apnea ...
MedPage Today

No Improved Outcomes for HF Patients With Sleep Apnea Using ASV Breathing Devices

Breathing machines with adaptive servo-ventilation (ASV) did not improve survival or other clinical outcomes in patients with heart failure (HF) and reduced ejection fraction and sleep-disordered ...